Skip to main content
logo
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
23.43
-0.44 (-1.84%)
At close: May 22, 2026, 4:00 PM EDT
23.89
+0.46 (1.96%)
After-hours: May 22, 2026, 7:58 PM EDT

Arcus Biosciences Revenue

Arcus Biosciences had revenue of $17.00M in the quarter ending March 31, 2026, a decrease of -39.29%. This brings the company's revenue in the last twelve months to $236.00M, up 67.38% year-over-year. In the year 2025, Arcus Biosciences had annual revenue of $247.00M, down -4.26%.

Revenue (ttm)
$236.00M
Revenue Growth
+67.38%
P/S Ratio
12.49
Revenue / Employee
$392,679
Employees
601
Market Cap
2.95B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025247.00M-11.00M-4.26%
Dec 31, 2024258.00M141.00M120.51%
Dec 31, 2023117.00M5.00M4.46%
Dec 31, 2022112.00M-271.00M-70.76%
Dec 31, 2021383.00M305.00M391.03%
Dec 31, 202078.00M63.00M420.00%
Dec 31, 201915.00M6.65M79.58%
Dec 31, 20188.35M6.94M491.15%
Dec 31, 20171.41M--
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Telix Pharmaceuticals803.79M
Tarsus Pharmaceuticals535.08M
Arcutis Biotherapeutics415.62M
Beam Therapeutics164.01M
Tango Therapeutics56.99M
Relay Therapeutics10.68M
Alumis8.40M
Revenue Rankings

RCUS News

More News